1. Home
  2. OPK vs UVV Comparison

OPK vs UVV Comparison

Compare OPK & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • UVV
  • Stock Information
  • Founded
  • OPK 2007
  • UVV 1886
  • Country
  • OPK United States
  • UVV United States
  • Employees
  • OPK N/A
  • UVV N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • UVV Farming/Seeds/Milling
  • Sector
  • OPK Health Care
  • UVV Industrials
  • Exchange
  • OPK Nasdaq
  • UVV Nasdaq
  • Market Cap
  • OPK 1.1B
  • UVV 1.3B
  • IPO Year
  • OPK 1995
  • UVV N/A
  • Fundamental
  • Price
  • OPK $1.52
  • UVV $53.65
  • Analyst Decision
  • OPK Buy
  • UVV
  • Analyst Count
  • OPK 3
  • UVV 0
  • Target Price
  • OPK $2.63
  • UVV N/A
  • AVG Volume (30 Days)
  • OPK 1.9M
  • UVV 182.2K
  • Earning Date
  • OPK 11-06-2025
  • UVV 08-06-2025
  • Dividend Yield
  • OPK N/A
  • UVV 6.11%
  • EPS Growth
  • OPK N/A
  • UVV N/A
  • EPS
  • OPK N/A
  • UVV 4.11
  • Revenue
  • OPK $664,029,000.00
  • UVV $2,943,996,000.00
  • Revenue This Year
  • OPK N/A
  • UVV $1.52
  • Revenue Next Year
  • OPK $0.97
  • UVV $0.97
  • P/E Ratio
  • OPK N/A
  • UVV $13.07
  • Revenue Growth
  • OPK N/A
  • UVV 4.11
  • 52 Week Low
  • OPK $1.11
  • UVV $49.40
  • 52 Week High
  • OPK $2.04
  • UVV $67.33
  • Technical
  • Relative Strength Index (RSI)
  • OPK 54.40
  • UVV 45.45
  • Support Level
  • OPK $1.48
  • UVV $52.72
  • Resistance Level
  • OPK $1.56
  • UVV $53.55
  • Average True Range (ATR)
  • OPK 0.05
  • UVV 0.84
  • MACD
  • OPK -0.01
  • UVV -0.16
  • Stochastic Oscillator
  • OPK 34.62
  • UVV 42.00

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

Share on Social Networks: